OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	37
The role of personality traits in following quarantine orders during the COVID-19 pandemic	29
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	18
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	17
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	17
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	16
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	14
Antidepressant psychopharmacology: is inflammation a future target?	13
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	13
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	13
Open issues in bipolar and antipsychotic treatments	11
Clinical specificity profile for novel rapid acting antidepressant drugs	11
Managing depression in the elderly: real-world clinical considerations and perspectives	11
Case series on aripiprazole and dopamine supersensitivity psychosis	10
Doxazosin improved COVID-19 associated nightmare in a patient with major depressive disorder: a case report with a positive rechallenge	10
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	10
Debated issues in major psychoses	9
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	9
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	9
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	9
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	9
The Gordian knot of the immune-redox systems’ interactions in psychosis	9
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	9
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	9

Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	8
Modulating factors in mood disorders treatment	8
Elevated liver transaminases among patients with psychiatric disorders	8
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	8
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	8
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	8
Innovation in psychopharmacology	8
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	7
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	7
Allergic reaction induced by subcutaneous administration of ketamine: a case report	6
Interplay of environmental and clinical factors in psychiatric disorders	6
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	6
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	6
The challenge of managing difficult to treat psychiatric conditions	5
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	5
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	5
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	5
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	5
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	5
Manic episode in a patient with pancreatic adenocarcinoma: a case report	5
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	5
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	5
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	5
Advances in the treatment of depression	5